{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:42:16Z","timestamp":1772163736582,"version":"3.50.1"},"reference-count":29,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"unspecified","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"The Gatsby Foundation","award":["GAT3676"],"award-info":[{"award-number":["GAT3676"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,1,8]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The PRIME-UK randomised controlled trial (RCT) aims to establish whether a model of care that seeks to be proactive, integrated and empower participants, caregivers and healthcare professionals can improve outcomes in people with parkinsonism. Given that this intervention is novel and complex, understanding whether and how the intervention will be acceptable, implementable, cost-effective and scalable across contexts are key questions beyond that of whether \u2018it works\u2019. We describe an embedded process evaluation to answer these questions, which aims to support interpretation of the trial results, refinement of the intervention and support future scaling of the PRIME-Parkinson model of care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>A mixed-methods approach will be used to collect data across four process evaluation domains: implementation, mechanism of change, acceptability and context. Quantitative data will be collected prospectively from all participants and analysed descriptively with exploratory tests of relationships as power allows. Qualitative data will be collected through semistructured interviews with a purposively sampled subpopulation of participants, caregivers and staff members as well as case studies where relevant. Interview transcripts will be analysed thematically using interpretive qualitative analysis. Synthesis of quantitative and qualitative data will also be performed to draw conclusions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The quantitative data will be collected as part of the main PRIME-UK RCT which was been granted NHS REC approval (21\/LO\/0387) on 27 July 2021. The qualitative data will be collected as part of a substudy, \u2018PRIME-Qual\u2019, which was granted NHS REC approval (21\/LO\/0388) on 14 July 2021. The mixed-methods process evaluation will be published after the conclusion of the trial in addition to the main trial findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05127057\">NCT05127057<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-086353","type":"journal-article","created":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T20:50:25Z","timestamp":1738529425000},"page":"e086353","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring how PRIME-Parkinson care is implemented and whether, how and why it produces change, for who and under what conditions: a protocol for an embedded process evaluation within the PRIME-UK randomised controlled trial"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct05127057","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05127057","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9522-4610","authenticated-orcid":false,"given":"Katherine","family":"Lloyd","sequence":"first","affiliation":[{"name":"Ageing and Movement Research Group, Population Health Sciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2330-8844","authenticated-orcid":false,"given":"Emma","family":"Tenison","sequence":"additional","affiliation":[{"name":"Ageing and Movement Research Group, Population Health Sciences, University of Bristol, Bristol, UK"},{"name":"Older People's Unit, Royal United Hospital Bath NHS Trust, Bath, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safi","family":"Smith","sequence":"additional","affiliation":[{"name":"Ageing and Movement Research Group, Population Health Sciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4542-7924","authenticated-orcid":false,"given":"Fiona","family":"Lithander","sequence":"additional","affiliation":[{"name":"Liggins Institute, University of Auckland, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1054-6758","authenticated-orcid":false,"given":"Judi","family":"Kidger","sequence":"additional","affiliation":[{"name":"Population Health Sciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9608-7451","authenticated-orcid":false,"given":"Heather","family":"Brant","sequence":"additional","affiliation":[{"name":"Population Health Sciences, University of Bristol, Bristol, UK"},{"name":"NIHR ARC West, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2159-1482","authenticated-orcid":false,"given":"Sabi","family":"Redwood","sequence":"additional","affiliation":[{"name":"Population Health Sciences, University of Bristol, Bristol, UK"},{"name":"NIHR ARC West, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6648-3007","authenticated-orcid":false,"given":"Yoav","family":"Ben-Shlomo","sequence":"additional","affiliation":[{"name":"Ageing and Movement Research Group, Population Health Sciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0016-1870","authenticated-orcid":false,"given":"Emily J","family":"Henderson","sequence":"additional","affiliation":[{"name":"Ageing and Movement Research Group, Population Health Sciences, University of Bristol, Bristol, UK"},{"name":"Older People's Unit, Royal United Hospital Bath NHS Trust, Bath, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,2,2]]},"reference":[{"key":"2025120520463950000_15.1.e086353.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30295-3"},{"key":"2025120520463950000_15.1.e086353.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30299-5"},{"key":"2025120520463950000_15.1.e086353.3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2006.100107"},{"key":"2025120520463950000_15.1.e086353.4","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A"},{"key":"2025120520463950000_15.1.e086353.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2005.06.011"},{"key":"2025120520463950000_15.1.e086353.6","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20609"},{"key":"2025120520463950000_15.1.e086353.7","unstructured":"World Health Organization . Delivering quality health services. 2018."},{"key":"2025120520463950000_15.1.e086353.8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/ejn.14094","article-title":"The clinical heterogeneity of Parkinson\u2019s disease and its therapeutic implications","volume":"49","author":"Greenland","year":"2019","journal-title":"Eur J Neurosci"},{"key":"2025120520463950000_15.1.e086353.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(01)00015-3"},{"key":"2025120520463950000_15.1.e086353.10","unstructured":"Parkinson\u2019s UK . UK parkinson\u2019s audit. 2022."},{"key":"2025120520463950000_15.1.e086353.11","doi-asserted-by":"publisher","DOI":"10.1016\/J.PARKRELDIS.2020.11.024"},{"key":"2025120520463950000_15.1.e086353.12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3233\/JPD-181431","article-title":"The Voice of the Parkinson Customer","volume":"9","author":"Vlaanderen","year":"2019","journal-title":"J Parkinsons Dis"},{"key":"2025120520463950000_15.1.e086353.13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1474-4422(20)30064-8","article-title":"Integrated and patient-centred management of Parkinson\u2019s disease: a network model for reshaping chronic neurological care","volume":"19","author":"Bloem","year":"2020","journal-title":"Lancet Neurol"},{"key":"2025120520463950000_15.1.e086353.14","article-title":"Proactive and Integrated Management and Empowerment in Parkinson\u2019s Disease: Designing a New Model of Care","volume":"2020","author":"Tenison","year":"2020","journal-title":"Parkinsons Dis"},{"key":"2025120520463950000_15.1.e086353.15","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-021-02308-3","article-title":"Rationale and design to evaluate the PRIME Parkinson care model: a prospective observational evaluation of proactive, integrated and patient-centred Parkinson care in The Netherlands (PRIME-NL)","volume":"21","author":"Ypinga","year":"2021","journal-title":"BMC Neurol"},{"key":"2025120520463950000_15.1.e086353.16","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-023-07084-8","article-title":"Proactive and Integrated Management and Empowerment in Parkinson\u2019s Disease protocol for a randomised controlled trial (PRIME-UK) to evaluate a new model of care","volume":"24","author":"Lithander","year":"2023","journal-title":"Trials"},{"key":"2025120520463950000_15.1.e086353.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n2061","article-title":"A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance","volume":"374","author":"Skivington","year":"2021","journal-title":"BMJ"},{"key":"2025120520463950000_15.1.e086353.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h1258","article-title":"Process evaluation of complex interventions: Medical Research Council guidance","volume":"350","author":"Moore","year":"2015","journal-title":"BMJ"},{"key":"2025120520463950000_15.1.e086353.19","doi-asserted-by":"publisher","DOI":"10.1136\/jech.2005.037242"},{"key":"2025120520463950000_15.1.e086353.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2005.00438.x"},{"key":"2025120520463950000_15.1.e086353.21","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000160375.47920.8c"},{"key":"2025120520463950000_15.1.e086353.22","doi-asserted-by":"publisher","DOI":"10.1207\/s15327752jpa5503&4_17"},{"key":"2025120520463950000_15.1.e086353.23","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3233\/JPD-240071","article-title":"Digital Intervention Promoting Physical Activity in People Newly Diagnosed with Parkinson\u2019s Disease: Feasibility and Acceptability of the Knowledge, Exercise-Efficacy and Participation (KEEP) Intervention","volume":"14","author":"Agley","year":"2024","journal-title":"J Parkinsons Dis"},{"key":"2025120520463950000_15.1.e086353.24","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22340"},{"key":"2025120520463950000_15.1.e086353.25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/mds.27862","article-title":"The Movement Disorder Society Nonmotor Rating Scale: Initial Validation Study","volume":"35","author":"Chaudhuri","year":"2020","journal-title":"Mov Disord"},{"key":"2025120520463950000_15.1.e086353.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53221.x"},{"key":"2025120520463950000_15.1.e086353.27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006645","article-title":"A Frailty Instrument for primary care for those aged 75 years or more: findings from the Survey of Health, Ageing and Retirement in Europe, a longitudinal population-based cohort study (SHARE-FI75+)","volume":"4","author":"Romero-Ortuno","year":"2014","journal-title":"BMJ Open"},{"key":"2025120520463950000_15.1.e086353.28","doi-asserted-by":"publisher","DOI":"10.1300\/J083v35n04_04"},{"key":"2025120520463950000_15.1.e086353.29","doi-asserted-by":"crossref","DOI":"10.1111\/hex.13914","article-title":"Working with public contributors in Parkinson\u2019s research: What were the changes, benefits and learnings? A critical reflection from the researcher and public contributor perspective","volume":"27","author":"Lithander","year":"2024","journal-title":"Health Expect"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-086353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:46:50Z","timestamp":1764996410000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-086353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,2]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/bmjopen-2024-086353"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-086353","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.12.23.24319541","asserted-by":"object"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}